Utility of SARC-F for Assessing Physical Function in Elderly Patients With Cardiovascular Disease

被引:72
|
作者
Tanaka, Shinya [1 ]
Kamiya, Kentaro [2 ]
Hamazaki, Nobuaki [1 ,2 ]
Matsuzawa, Ryota [2 ]
Nozaki, Kohei [2 ]
Maekawa, Emi [3 ]
Noda, Chiharu [3 ]
Yamaoka-Tojo, Minako [1 ,4 ]
Matsunaga, Atsuhiko [1 ,4 ]
Masuda, Takashi [1 ,4 ]
Ako, Junya [1 ,3 ]
机构
[1] Kitasato Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Sagamihara, Kanagawa, Japan
[2] Kitasato Univ Hosp, Dept Rehabil, Sagamihara, Kanagawa, Japan
[3] Kitasato Univ, Dept Cardiovasc Med, Sch Med, Sagamihara, Kanagawa, Japan
[4] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Sagamihara, Kanagawa, Japan
关键词
Sarcopenia; screening; SARC-F; physical function; elderly; cardiovascular disease; RESPIRATORY MUSCLE STRENGTH; CHRONIC HEART-FAILURE; OLDER-ADULTS; SARCOPENIA; DISABILITY; PREDICTOR; MORTALITY; ASSOCIATION; PERFORMANCE; PROGNOSIS;
D O I
10.1016/j.jamda.2016.10.019
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: A simple and inexpensive tool for screening of sarcopenia would be helpful for clinicians. The present study was performed to determine whether the SARC-F questionnaire is useful in screening of patients with cardiovascular disease (CVD) for impaired physical function. Design: Cross-sectional study. Setting: Single university hospital. Participants: A total of 235 Japanese patients >= 65 years old admitted to our hospital for CVD. Measurements: SARC-F, handgrip strength, leg strength, respiratory muscle strength, standing balance, usual gait speed, Short Physical Performance Battery (SPPB) score, and 6-minute walking distance were measured before discharge from hospital. The patients were divided into 2 groups according to SARC-F score: SARC-F < 4 (nonsarcopenia group) and SARC-F >= 4 ( sarcopenia group). Results: The sarcopenia prevalence rate was 25.5% and increased with age (P trend <.001). The sarcopenia group ( SARC-F score >= 4) had significantly lower handgrip strength, leg strength, and respiratory muscle strength, poorer standing balance, slower usual gait speed, lower SPPB score, and shorter 6-minute walking distance compared to the nonsarcopenia group (SARC-F score < 4). Patients in the sarcopenia group had consistently poorer physical function even after adjusting for covariates. Conclusion: The SARC-F questionnaire is a useful screening tool for impaired physical function in elderly CVD patients. These findings support the use of the SARC-F for screening in hospital settings. (C) 2016 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
引用
收藏
页码:176 / 181
页数:6
相关论文
共 50 条
  • [21] Validity of Japanese version of SARC-F questionnaire in patients with chronic liver disease
    Ida, Satoshi
    Kojima, Yuji
    Hamaoka, Shima
    Urawa, Naohito
    Araki, Jun
    Kaneko, Ryutaro
    Murata, Kazuya
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (05) : 947 - 953
  • [22] THE ASSOCIATION OF SARC-F SCORE WITH ATHEROSCLEROSIS IN ELDERLY RESIDENTS OF CARE HOMES
    Varaeva, Y.
    Kiknadze, T.
    Shaposhnikova, N.
    Prunceva, T.
    Polenova, N.
    Starodubova, A.
    ATHEROSCLEROSIS, 2023, 379 : S202 - S202
  • [23] Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study
    Rolland, Yves
    Dupuy, Charlotte
    Van Kan, Gabor Abellan
    Cesari, Matteo
    Vellas, Bruno
    Faruch, Marie
    Dray, Cedric
    Barreto, Philipe de Souto
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2017, 18 (10) : 848 - 852
  • [24] Association of SARC-F and dissociation of SARC-F + calf circumference with comorbidities in older hospitalized cancer patients (vol 148, 111315, 2021)
    Mainardi, Lara G.
    Borges, Thais C.
    Gomes, Tatyanne L. N.
    Pichard, Claude
    Laviano, Alessandro
    Pimentel, Gustavo D.
    EXPERIMENTAL GERONTOLOGY, 2022, 164
  • [25] SARC-F, SARC-CalF, and SARC-F plus EBM as practical predictive tools for the risk of pneumonia in patients with stable schizophrenia-a - a prospective study
    Huang, Sha
    Chen, Ming
    Zhu, Tian
    Lei, Xiuping
    Li, Qiuxia
    Tan, Youguo
    Chen, Xiaoyan
    HELIYON, 2024, 10 (15)
  • [26] SARC-F Is a Predictor of Longer LOS and Hospital Readmission in Hospitalized Patients after a Cardiovascular Event
    Trussardi Fayh, Ana Paula
    de Oliveira Guedes, Francisco Felipe
    Filgueira Calado, Guilherme Carlos
    Queiroz, Sandra Azevedo
    Gomes Barbosa Anselmo, Marina Gabriely
    de Sousa, Iasmin Matias
    NUTRIENTS, 2022, 14 (15)
  • [27] Comparing SARC-F with SARC-CalF for screening sarcopenia in advanced cancer patients
    Fu, Xiaofen
    Tian, Zhen
    Thapa, Sudip
    Sun, Huihui
    Wen, Su
    Xiong, Huihua
    Yu, Shiying
    CLINICAL NUTRITION, 2020, 39 (11) : 3337 - 3345
  • [28] Clinical usefulness of the SARC-F questionnaire to assess sarcopenia in patients with Parkinson's disease
    Choi, Seohee
    Kim, Ryul
    Lee, Jee-Young
    Jeon, Beomseok
    PARKINSONISM & RELATED DISORDERS, 2024, 125
  • [29] Identifying Patients with Osteoarthritis at Risk of Sarcopenia using the SARC-F
    Lovett, Maggie
    Negm, Ahmed
    Ioannidis, George
    Petrucelli, Danielle
    Winemaker, Mitchell
    Adachi, Jonathan D.
    Papaioannou, Alexandra
    CANADIAN GERIATRICS JOURNAL, 2021, 24 (01) : 1 - 7
  • [30] Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis
    Imamura, Keigo
    Yamamoto, Shohei
    Suzuki, Yuta
    Matsuzawa, Ryota
    Harada, Manae
    Yoshikoshi, Shun
    Yoshida, Atsushi
    Matsunaga, Atsuhiko
    NEPHRON, 2022, 146 (01) : 32 - 39